Atossa Therapeutics, Inc. (ATOS): 8-K filed Apr 16, 2026

Form type

8-K

Filing date

Apr 16, 2026

Accession number

0001193125-26-158030

Filer

Atossa Therapeutics, Inc. (CIK 1488039)